An aide memoire for model-based drug development--a new key for the interpretation of the erythromycin breath test--therapeutic index as a biomarker for smart drug development.
作者信息
Boutouyrie-Dumont Bruno
机构信息
Clinical Pharmacology Department, Shire AG, Business Park Terre-Bonne, Route de Crassier 15, 1262 Eysins, Switzerland.
出版信息
Biomark Med. 2013 Feb;7(1):89-91. doi: 10.2217/bmm.12.101.
PMID:23387489
Abstract
摘要
相似文献
1
An aide memoire for model-based drug development--a new key for the interpretation of the erythromycin breath test--therapeutic index as a biomarker for smart drug development.基于模型的药物开发辅助记忆——解读红霉素呼气试验的新关键——治疗指数作为智能药物开发的生物标志物。
Biomark Med. 2013 Feb;7(1):89-91. doi: 10.2217/bmm.12.101.
2
Cytochrome P450-3A phenotyping using midazolam is not altered by OATP1B1 polymorphisms.使用咪达唑仑进行细胞色素P450 - 3A表型分析不受OATP1B1基因多态性的影响。
Clin Pharmacol Ther. 2013 May;93(5):388. doi: 10.1038/clpt.2013.46. Epub 2013 Feb 28.
3
A step closer to personalized chemotherapy: consideration of the influence of genetic variation in hepatic uptake transporters on the metabolism of CYP3A substrates.更接近个性化化疗：考虑肝摄取转运体的遗传变异对 CYP3A 底物代谢的影响。
Clin Pharmacol Ther. 2012 Nov;92(5):551-2. doi: 10.1038/clpt.2012.165.
4
Drug labels: a flawed source of data for studying orphan drug approvals.药品标签：用于研究罕见病药物批准情况的有缺陷的数据来源。
Clin Pharmacol Ther. 2012 Dec;92(6):694; author reply 695. doi: 10.1038/clpt.2012.166. Epub 2012 Oct 17.
5
Quantitative analysis to guide orphan drug development.定量分析指导孤儿药开发。
Clin Pharmacol Ther. 2012 Aug;92(2):258-61. doi: 10.1038/clpt.2012.80. Epub 2012 Jun 27.
6
Effective global drug development strategy for obtaining regulatory approval in Japan in the context of ethnicity-related drug response factors.在与种族相关的药物反应因素背景下，获得日本监管批准的有效全球药物开发策略。
Clin Pharmacol Ther. 2010 Mar;87(3):362-6. doi: 10.1038/clpt.2009.285. Epub 2010 Jan 27.
7
Raising orphans: how clinical development programs of drugs for rare and common diseases are different.孤儿药的研发：罕见病和常见病药物的临床开发项目有何不同。
Clin Pharmacol Ther. 2012 Aug;92(2):262-4. doi: 10.1038/clpt.2012.87. Epub 2012 Jun 27.
8
Prospects for rapid advances in the development of new medicines for special medical needs.特殊医疗需求新药研发的快速进展前景。
Clin Pharmacol Ther. 2014 Jan;95(1):98-109. doi: 10.1038/clpt.2013.155. Epub 2013 Aug 5.
9
Accelerating orphan drug development.加速孤儿药研发。
Nat Rev Drug Discov. 2010 Dec;9(12):901-2. doi: 10.1038/nrd3340.
10
The determination and interpretation of the therapeutic index in drug development.药物研发中治疗指数的确定和解读。
Nat Rev Drug Discov. 2012 Oct;11(10):751-61. doi: 10.1038/nrd3801. Epub 2012 Aug 31.
Zotero 插件